UBE2S and cervical carcinoma: Our findings suggest that the downregulation of UBE2S expression by lignocaine and quercetin may inhibit epithelial-mesenchymal transition (EMT) and impede cervical cancer metastasis, thereby highlighting UBE2S as a promising therapeutic target for cervical cancer [43].